Health and Healthcare
180 Articles
Here are some of the top stories affecting key drug and biotech stocks that are covered in-depth today at BioHealthInvestor.com:…
These are the top 10 early bird analyst upgrades and downgrades we have seen in Wall Street research calls early…
These are the top pre-market analyst upgrades and positive research calls from Wall Street we have seen this Wednesday morning…
These are some of the top upgrades and positive calls we have seen from analysts on Wall Street this Wednesday…
It is getting rather thin in analyst coverage, but these are the top ten analyst upgrades and downgrades we have…
Below are some of the top analyst calls we are seeing from Wall Street firms this Thursday morning: Biogen Idec…
Moneygram (MGI) Deal to buy company falls apart. Drops to $2.45 from 52-week high of $30.67. Universal American Financial (UAM)…
Nortel (NT) Nine-to-one this dog never hits bottom. Down to $9.05 from 52-week high of $30. Mylan (MYL) Market unhappy…
Mylan Inc. (NYSE: MYL) has been removed from the Goldman Sachs Conviction List, although the firm is not downgrading its…
Below is the top news that 247WallSt.com is focusing on that is impacting stocks in pre-market trading activity: Adobe Systems…
These are not the only analyst impact calls, but these are the top research notes that 247WallSt.com is focusing on:…
These are not the only impact analyst calls today, but these are the top calls that 24/7 Wall St. is…
AAPL started as Buy at BMO Capital.AVR cut to Neutral at JPMorgan.BIOF cut to Neutral at JPMorgan.CHIC cut to Neutral…
Mylan Labs (MYL-NYSE) is seeing its shares take a beating because it is acquiring Merck KGaA’s generic unit and Mylan…
(ACL) Alcan’s buyout bid by Alcoa is reportedly getting big interest from larger names such as Rio Tinto and others.(BRLC)…
Our top personal finance-related articles today. Your wallet will thank you later.